$129.00
This blend combines PLP-CAG, a long-acting amylin receptor agonist, with PLP-SM, a synthetic research peptide, in a single lyophilized vial. The combination is studied to examine two distinct, complementary receptor pathways within one research formulation.
Mechanism & Research Rationale:
PLP-SM is studied for its receptor-binding characteristics and related molecular signaling activity. PLP-CAG, by contrast, is an amylin analog that engages amylin receptors through a mechanistically distinct pathway involving calcitonin/amylin receptor signaling. The combination provides a research model for examining interactions between distinct receptor systems and their respective signaling pathways.
Key Research Areas:
Product Specifications:
For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved. This research-grade product is intended solely for non-clinical laboratory and analytical research applications and is not intended for any therapeutic or clinical use.
We take pride in treating every client, large or small, with the utmost regard.
No products in the cart.
Please confirm both statements before entering this website.
By entering, I acknowledge and agree to the Terms & Conditions and Privacy Policy.
Access remains blocked until both acknowledgments are selected.